Zannes Maria 4
4 · bioAffinity Technologies, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Zannes Maria
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-07-01+33,784→ 243,322 total
Footnotes (1)
- [F1]Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.